3.連結財務諸表及び主な注記
(1)連結純損益計算書
| | | |
| | | (単位:百万円) |
| 前連結会計年度 (自 2017年4月1日 至 2018年3月31日) | | 当連結会計年度 (自 2018年4月1日 至 2019年3月31日) |
売上収益 | 1,300,316 | | 1,306,348 |
売上原価 | △294,250 | | △292,050 |
売上総利益 | 1,006,066 | | 1,014,299 |
| | | |
販売費及び一般管理費 | △478,330 | | △490,263 |
研究開発費 | △220,781 | | △208,682 |
無形資産償却費 | △35,838 | | △35,212 |
持分法による投資損益 | △2,419 | | △1,627 |
その他の収益 | 11,872 | | 14,152 |
その他の費用 | △67,311 | | △48,755 |
営業利益 | 213,258 | | 243,912 |
| | | |
金融収益 | 6,637 | | 6,358 |
金融費用 | △1,782 | | △1,302 |
税引前利益 | 218,113 | | 248,967 |
法人所得税費用 | △53,434 | | △26,702 |
当期利益 | 164,679 | | 222,265 |
| | | |
当期利益の帰属 | | | |
親会社の所有者 | 164,679 | | 222,265 |
| | | |
1株当たり当期利益 | | | |
基本的1株当たり当期利益(円) | 81.11 | | 115.05 |
希薄化後1株当たり当期利益(円) | 81.02 | | 114.94 |
E0092045030アステラス製薬株式会社Astellas Pharma Inc.通期第3号参考様式 [IFRS](連結)IFRStrueCTECTE2018-04-012019-03-31FY2019-03-312017-04-012018-03-312018-03-311falsefalsefalse450302019-03-31450302018-04-012019-03-31450302018-03-31450302017-04-012018-03-31450302017-03-31450302017-04-012018-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302017-04-012018-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302017-04-012018-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302017-04-012018-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302017-04-012018-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302017-04-012018-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302017-04-012018-03-31jpigp_cor:RetainedEarningsIFRSMember450302017-04-012018-03-31jpigp_cor:TreasurySharesIFRSMember450302017-04-012018-03-31jpigp_cor:CapitalSurplusIFRSMember450302017-04-012018-03-31jpigp_cor:ShareCapitalIFRSMember450302017-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302017-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302017-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302017-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302017-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302017-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302017-03-31jpigp_cor:RetainedEarningsIFRSMember450302017-03-31jpigp_cor:TreasurySharesIFRSMember450302017-03-31jpigp_cor:CapitalSurplusIFRSMember450302017-03-31jpigp_cor:ShareCapitalIFRSMember450302019-04-25450302018-04-012019-03-31jpigp_cor:TreasurySharesIFRSMember450302018-04-012019-03-31jpigp_cor:CapitalSurplusIFRSMember450302018-04-012019-03-31jpigp_cor:ShareCapitalIFRSMember450302018-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302018-03-31jpigp_cor:RetainedEarningsIFRSMember450302018-03-31jpigp_cor:TreasurySharesIFRSMember450302018-03-31jpigp_cor:CapitalSurplusIFRSMember450302018-03-31jpigp_cor:ShareCapitalIFRSMember450302018-04-012019-03-31jpigp_cor:RetainedEarningsIFRSMember450302019-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302019-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302019-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302019-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302019-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302019-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-03-31jpigp_cor:RetainedEarningsIFRSMember450302019-03-31jpigp_cor:TreasurySharesIFRSMember450302019-03-31jpigp_cor:CapitalSurplusIFRSMember450302019-03-31jpigp_cor:ShareCapitalIFRSMember450302018-04-012019-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-04-012019-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-04-012019-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-04-012019-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-04-012019-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-04-012019-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-04-012019-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302017-04-012018-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302017-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMemberxbrli:pureiso4217:JPYiso4217:JPYxbrli:shares